Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples